
Sign up to save your podcasts
Or


If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
By The Observer4.6
1515 ratings
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.

428 Listeners

277 Listeners

841 Listeners

141 Listeners

1,015 Listeners

277 Listeners

170 Listeners

257 Listeners

3 Listeners

28 Listeners

3,472 Listeners

71 Listeners

3,858 Listeners

1,314 Listeners

1,178 Listeners

54 Listeners

454 Listeners

45 Listeners

36 Listeners

492 Listeners

907 Listeners

1 Listeners

14 Listeners

48 Listeners

6 Listeners

170 Listeners

5 Listeners

13 Listeners

14 Listeners

84 Listeners

4 Listeners